Akebia Therapeutics Inc (AKBA)

[QCAVN]

Hear me out. So who would benifit from a serious drop in price and maintaining a sell rating even though the consensus is 5-9$ a share? If its rated from strong sell to a sell still but not a buy why would hedge funds be increasing stake size in a failing company?

https://www.dailypolitical.com/2020/09/23/akebia-therapeutics-nasdaqakba-upgraded-to-sell-at-bidaskclub.html

"A number of hedge funds have recently made changes to their positions in the business. Valeo Financial Advisors LLC raised its position in Akebia Therapeutics by 10.7% in the second quarter. Valeo Financial Advisors LLC now owns 8,245 shares of the biopharmaceutical company’s stock worth $112,000 after acquiring an additional 800 shares during the period. Ameritas Investment Partners Inc. raised its position in Akebia Therapeutics by 13.3% in the second quarter. Ameritas Investment Partners Inc. now owns 11,500 shares of the biopharmaceutical company’s stock worth $156,000 after acquiring an additional 1,352 shares during the period. Two Sigma Investments LP raised its position in Akebia Therapeutics by 9.8% in the first quarter. Two Sigma Investments LP now owns 19,827 shares of the biopharmaceutical company’s stock worth $150,000 after acquiring an additional 1,777 shares during the period. Private Advisor Group LLC bought a new stake in Akebia Therapeutics in the second quarter worth about $25,000. Finally, PNC Financial Services Group Inc. bought a new stake in Akebia Therapeutics in the second quarter worth about $28,000. 76.75% of the stock is currently owned by institutional investors and hedge funds."